Shin Nippon Biomedical Laboratories Ltd
TSE:2395
Shin Nippon Biomedical Laboratories Ltd
Operating Income
Shin Nippon Biomedical Laboratories Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
|
Operating Income
¥4B
|
CAGR 3-Years
21%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
CMIC Holdings Co Ltd
TSE:2309
|
Operating Income
¥5.5B
|
CAGR 3-Years
30%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
Medinet Co Ltd
TSE:2370
|
Operating Income
-¥1.4B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-4%
|
|
CellSource Co Ltd
TSE:4880
|
Operating Income
¥1.2B
|
CAGR 3-Years
43%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Linical Co Ltd
TSE:2183
|
Operating Income
¥1.2B
|
CAGR 3-Years
50%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
4%
|
|
WDB coco Co Ltd
TSE:7079
|
Operating Income
¥1.1B
|
CAGR 3-Years
32%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
See Also
What is Shin Nippon Biomedical Laboratories Ltd's Operating Income?
Operating Income
4B
JPY
Based on the financial report for Dec 31, 2023, Shin Nippon Biomedical Laboratories Ltd's Operating Income amounts to 4B JPY.
What is Shin Nippon Biomedical Laboratories Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
37%
Over the last year, the Operating Income growth was -15%. The average annual Operating Income growth rates for Shin Nippon Biomedical Laboratories Ltd have been 21% over the past three years , 37% over the past five years .